NEW YORK, NY / ACCESS Newswire / March 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CARGO ...

LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

CARGO announced in a press release issued on January 29, 2025, that it "has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma (LBCL ...

CARGO intends to present an analysis of the FIRCE-1 Phase 2 study at a future medical conference. CARGO Therapeutics, Inc. is a clinical-stage biotechnology company advancing next-generation ...

CARGO announced in a press release issued on January 29, 2025, that it "has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma (LBCL ...

CARGO Therapeutics , Inc. (NASDAQ:CRGX), a clinical-stage biotech company currently valued at $628 million, announced today the discontinuation of its Phase 2 clinical study, FIRCE-1, for the ...

Air Force One has evolved significantly over the years, as avionics and flight technology has improved and innovated across ...

Pomerantz LLP is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("Cargo" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...

China has announced the successful completion of its first intercity cargo drone flight, marking a significant step in integrating artificial intelligence technologies into the aviation sector.